NELA BioDynamics selected for LSI Investor Event

NELA BioDynamics is excited to announce that has been selected by LSI to participate in its annual event LSI Emerging MedTech Summit 2022 from 15-18th March. This event brings together a large number of world-class investors and players from the health sector in Dana...

NELA BioDynamics makes its first steps into the USA

NELA BioDynamics has been accepted into the Octane LaunchPad SBDC accelerator that ranks in the top 5 out of over 900 SBDCs in the United States. Octane is a convening organization of the Southern California technology and medical technology business ecosystem by...

NELA BioDynamics obtained a grant from IVACE

NELA BioDynamics obtained a grant from the Valencian Institute of Business Competitiveness (IVACE) through the call CREATEC-CV-2020. This call is oriented to supporting the development of innovative & technology-based companies whose activities are based on the...

NELA BioDynamics Exhibits in Vienna

INTERNATIONAL CONFERENCE ON ARTHROPLASTY AND ORTHOPEDIC SURGERY 21′ Last week, we had the opportunity to exhibit the results obtained in our pilot biological study at the International Conference on Arthroplasty in Vienna. The initial results presented show the...